CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies

Roberto Moretto, Daniele Rossini, Veronica Conca, Sara Lonardi, Cosimo Rasola, Carlotta Antoniotti, Daniele Santini, Federica Marmorino, Gianluca Tomasello, Beatrice Borelli, S Caponnetto, Gemma Zucchelli, Alberto Zaniboni, Margherita Ambrosini, Angela Buonadonna, Laura Fanchini, Samanta Cupini, Gianluca Masi, Alfredo Falcone, Chiara Cremolini